Ezetimibe and simvastatin (fixed combination)

Key facts

Invented name
INEGY and associated trade names
Active substance
  • Ezetimibe
  • simvastatin
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
PIP number
Ezetimibe and simvastatin (fixed combination)
Pharmaceutical form(s)
Condition(s) / indication(s)
  • Hypercholesterolaemia
  • Mixed (combined) hyperlipidaemia
  • Sitosterolaemia
Route(s) of administration
Oral use
Contact for public enquiries
Merck Sharp & Dohme Limited
The Netherlands
Tel. +33 180464738
E-mail: pip.information@merck.com
Decision type
W: decision granting a waiver in all age groups for all conditions or indications



How useful was this page?

Add your rating